Volume 140, Issue 3, Pages (March 2011)

Slides:



Advertisements
Similar presentations
Abnormal Liver Tests and Fatty Liver on Ultrasound
Advertisements

Hunger Games: Is Your Stomach Making You Fat?
Gastrointestinal Stromal Tumors: Disease and Treatment Update
Volume 152, Issue 4, Pages (March 2017)
Volume 141, Issue 5, Pages (November 2011)
Brian Bond, Judith Quinlan, George E. Dukes, Fermin Mearin, Ray E
Evaluation and Management of End-Stage Liver Disease in Children
Volume 140, Issue 6, Pages (May 2011)
Outcomes Among Living Liver Donors
Comparison of High-Resolution Melting Analysis, TaqMan Allelic Discrimination Assay, and Sanger Sequencing for Clopidogrel Efficacy Genotyping in Routine.
How to Critically Read the GI Epidemiology Literature
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 152, Issue 6, Pages (May 2017)
Volume 137, Issue 2, Pages (August 2009)
Volume 141, Issue 5, Pages (November 2011)
Covering the Cover Gastroenterology
Volume 155, Issue 4, Pages (October 2018)
Clinical Challenges and Images in GI
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 135, Issue 4, Pages (October 2008)
Dietary Fiber Intake Reduces Risk for Gastric Cancer: A Meta-analysis
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Volume 155, Issue 1, Pages (July 2018)
Volume 154, Issue 4, Pages (March 2018)
Lei Miao, XiangRong Chen, ZhiMing Huang  Gastroenterology 
Constipation and the Microbiome: Lumen Versus Mucosa!
Jean-Michel Pawlotsky  Gastroenterology 
Conducting a Microbiome Study
Colon Cancer: An Update and Future Directions
Gastrointestinal Stromal Tumors: Disease and Treatment Update
Volume 141, Issue 1, Pages (July 2011)
Volume 139, Issue 1, Pages e24 (July 2010)
Abnormal Liver Tests and Fatty Liver on Ultrasound
Volume 137, Issue 5, Pages e2 (November 2009)
Laura Rotundo, Sushil Ahlawat  Gastroenterology 
Coffee and Colorectal Cancer: Grounds for Prevention?
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Volume 133, Issue 2, Pages (August 2007)
Volume 150, Issue 7, Pages (June 2016)
Volume 155, Issue 2, Pages (August 2018)
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Caitlin C. Murphy, Kristin Wallace, Robert S. Sandler, John A. Baron 
Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis  Neeraj Narula, Abdul-Aziz Alshahrani,
Methionine Intake and Pancreatic Cancer Risk: Digesting the Evidence
Volume 149, Issue 6, Pages (November 2015)
Qiwen Ben, Yunwei Sun, Rui Chai, Aihua Qian, Bin Xu, Yaozong Yuan 
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Richard J. Saad, William D. Chey  Gastroenterology 
Volume 138, Issue 3, Pages (March 2010)
Swaroop Pendyala, Jeanne M. Walker, Peter R. Holt  Gastroenterology 
Covering the Cover Gastroenterology
Volume 156, Issue 4, Pages (March 2019)
Changing of the Guards: 2011–2016 Gastroenterology Team
Risks Associated With Anesthesia Services During Colonoscopy
Volume 135, Issue 1, Pages (July 2008)
Daniel Mønsted Shabanzadeh, Lars Tue Sørensen, Torben Jørgensen 
Would Free Fatty Acids Enhance Treatment of Obesity?
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Reply Gastroenterology
End-Stage Liver Disease in 2008: Finally a Glass Half Full
A Necrotic Liver Mass Gastroenterology
Volume 141, Issue 5, Pages (November 2011)
Electronic Clinical Challenges and Images in GI
Controversies in Liver Transplantation for Hepatitis C
A Rare Tumor of the Liver With a Sudden Presentation
Presentation transcript:

Volume 140, Issue 3, Pages 976-986 (March 2011) Association Between Composition of the Human Gastrointestinal Microbiome and Development of Fatty Liver With Choline Deficiency  Melanie D. Spencer, Timothy J. Hamp, Robert W. Reid, Leslie M. Fischer, Steven H. Zeisel, Anthony A. Fodor  Gastroenterology  Volume 140, Issue 3, Pages 976-986 (March 2011) DOI: 10.1053/j.gastro.2010.11.049 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Experimental design. Participants were fed a controlled research diet that included adequate daily choline intake during the baseline period (red). During depletion, subjects were fed a diet very low in choline until they showed signs of deficiency or for a maximum of 42 days (gray). The 10-day repletion diet was very rich in choline (green). Arrows indicate timing of stool samples. Gastroenterology 2011 140, 976-986DOI: (10.1053/j.gastro.2010.11.049) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Hierarchical clustering of gut microbiome samples. (A) Hierarchical clustering based on OTUs at 97% sequence similarity. Samples are colored by subject. (B) Hierarchical clustering based on ARISA profiles, a DNA fingerprinting technique. Gastroenterology 2011 140, 976-986DOI: (10.1053/j.gastro.2010.11.049) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 Diagrams of bacterial sequence proportions by time point at the class level. The key shows ordering of time points in the ring: B1, baseline; B2, standard diet; D1, choline-deficient diet; D2, end of choline-deficient diet; R1, high dietary choline sample; R2, second high dietary choline sample (subjects 34, 32, 37, 39). Blue subject labels designate those who developed fatty liver (liver fat change ≥28%) on a choline-deficient diet; those with red labels did not. Subjects 4 and 29 do not have all samples, and time points are labeled. Gastroenterology 2011 140, 976-986DOI: (10.1053/j.gastro.2010.11.049) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 Distribution of Gammaproteobacteria abundance by time point by subject. Plot of logged standardized sequence frequencies (log10) for Gammaproteobacteria colored by subject. Gastroenterology 2011 140, 976-986DOI: (10.1053/j.gastro.2010.11.049) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 Gammaproteobacteria and Erysipelotrichi abundance, particularly when combined with subject genotype, predicts choline deficiency–induced fatty liver. Regressions of (A) Gammaproteobacteria B1 abundance and (B) Erysipelotrichi B1 abundance against the LF/SF percent change from baseline (B1) to choline-deficient (D2) diet. (C) Regression of PCA1 from PCA of Gammaproteobacteria and Erysipelotrichi B1 abundance against the LF/SF percent change from B1 to D2. (D) Regression of PCA1 from PCA of PEMT genotype for rs12325817, Gammaproteobacteria and Erysipelotrichi B1 abundance (6B) against the LF/SF percent change from B1 to D2. Gastroenterology 2011 140, 976-986DOI: (10.1053/j.gastro.2010.11.049) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 The PEMT SNP affects risk of developing choline deficiency–induced fatty liver. (A) Variability plot of PEMT genotype for SNP rs12325817 and the percent change in LF/SF. WT, wild-type; HET, heterozygous; HO, homozygous. (B) PCA of PEMT genotype for rs12325817, Gammaproteobacteria, and Erysipelotrichi B1 abundance. Open circles indicate subjects who did not develop fatty liver; closed squares indicate subjects who did. Gastroenterology 2011 140, 976-986DOI: (10.1053/j.gastro.2010.11.049) Copyright © 2011 AGA Institute Terms and Conditions